Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MHC class II restricted neoantigen: A promising target in tumor immunotherapy.

Cancer letters - 28 Apr 2017

Sun Zhichen, Chen Fangjun, Meng Fanyan, Wei Jia, Liu Baorui

Abstract excerpt

Neoantigen is a patient-specific tumor antigen resulted from mutations during oncogenesis. Emerging data suggested that immune responsiveness against neoantigens correlated with the success of clinical tumor immunotherapies. Nowadays, the majority of studies on neoantigens have focused on MHC class I restricted antigens recognized by CD8+ T cells. With improved understanding of the underlying principles of tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Histocompatibility Antigens Class II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Immunotherapy, Adoptive

Share to Lymphocytes, Tumor-Infiltrating

Share to Tumor Escape

Share to Tumor Microenvironment

Source

Identifiers

PMID: 28104443
DOI: 10.1016/j.canlet.2016.12.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MHC class II restricted neoantigen: A promising target in tumor immunotherapy.PMID 28104443Read ↗

Tumor neoantigens: from basic research to clinical applicationsSemantic proximity Read ↗

Current Trends in Neoantigen-Based Cancer VaccinesSemantic proximity Read ↗

Cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.Semantic proximity Read ↗

The Role of Neoantigens in Cancer ImmunotherapySemantic proximity Read ↗

Engineering neoantigen vaccines to improve cancer personalized immunotherapySemantic proximity Read ↗

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Semantic proximity Read ↗

Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)Semantic proximity Read ↗

The role of neoantigens in response to immune checkpoint blockade.Semantic proximity Read ↗

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.Semantic proximity Read ↗

Cancer NeoantigensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.